Loading news...
Global instability is rising fast, but one income strategy may be built for exactly this kind of environment. These overlooked income machines combine bond-like stability with built-in growth most investors underestimate. If you're worried about inflation, AI disruption, and market turmoil, this may be the most dependable place left to hide.
While many Baby Boomers have enjoyed a long bull market over the past 35 years, there is a point when income becomes more critical than stock appreciation.
LAUSANNE, Switzerland, March 3, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that it will host a conference call and live webcast on Tuesday, March 10, 2026, at 8:30 a.m. EDT to report financial results for the fourth quarter and full year ended December 31, 2025, and provide operational updates.
LAUSANNE, Switzerland, March 2, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made grants of options to purchase an aggregate of 135,000 of the Company's common shares to three new employees on March 2, 2026 (each, a "Grant"). The Grants were offered as material inducement to the employees' employment.
Citigroup Inc. decreased its holdings in shares of Agree Realty Corporation (NYSE: ADC) by 73.5% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 163,161 shares of the real estate investment trust's stock after selling 453,050 shares during the quarter. Citigroup Inc. owned
A visit to Agree Realty shows why asset quality matters far more than headline yields. The gap between Agree and peers may be wider than investors realize. I explain what makes Agree the highest-quality net lease REIT.
Centersquare Investment Management LLC boosted its holdings in shares of Agree Realty Corporation (NYSE: ADC) by 1.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,896,229 shares of the real estate investment trust's stock after buying an additional 51,269 shares during the
Toronto, Ontario – TheNewswire - February 24, 2026 – Helix BioPharma Corp. (TSX: “HBP” , OTC PINK: “HBPCD” , FRANKFURT: “HBP0” ) ( “Helix” or the “Company” ), a clinical-stage oncology company shaping a near future where today's hard-to-treat cancers are vincible, is pleased to announce that the Company presented new data yesterday on its CEACAM6-directed antibody-drug conjugate (ADC) program at the 16 th Annual World ADC London conference, held in London, United Kingdom. The presentation, titled “Next-Generation ADCs: Unlocking the Potential of CEACAM6-Directed Targeted Therapies” , was delivered by Jonathan Davis, PhD, Director of ADC Discovery at Helix BioPharma, as part of the conference's opening day. Dr. Davis was selected to present as part of the conference's Seminar Day program, which brings together leading ADC experts to address key challenges and opportunities in next-generation conjugate design, safety, combination strategies, and regulatory development. His participation underscores Helix's growing leadership in the development of innovative ADC technologies. The World ADC London conference continues over the following two days with a comprehensive scientific program covering advances in ADC discovery, development, and clinical translation.
LAUSANNE, Switzerland, Feb. 24, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced participation in upcoming investor conferences in March: TD Cowen 46th Annual Health Care ConferenceDate: Tuesday, March 3, 2026Presentation Time: 11:50 a.m. ESTFormat: Corporate presentationSpeaker: Ameet Mallik, Chief Executive OfficerLocation: Boston, MATo register for the webcast, click here.
LAUSANNE, Switzerland, Feb. 23, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that it has entered into an amendment to its royalty purchase agreement with entities managed by HealthCare Royalty. Based on confidence in the long-term outlook for ZYNLONTA®, ADC Therapeutics negotiated mutually beneficial updated terms with HealthCare Royalty, offering greater strategic flexibility to the Company.
Net lease REITs like Realty Income, NNN, Agree Realty, and W. P. Carey are rebounding as falling treasury yields drive capital back to stable, long-duration assets. The sector's rally is fueled by a flight to safety amid turmoil in private credit and software, with REITs outperforming equity indices year-to-date. With weighted average lease terms of 10+ years, net lease REITs act as long-duration credit portfolios, highly sensitive to treasury yield movements.
Ultra-high-yield strategies (e.g., CLO equity, aggressive call option funds) risk capital destruction and income instability. Yet, conservative blue-chip income portfolios often yield too little (3-4%) to meet robust income goals or outpace inflation. My approach is to strike a balance between these two worlds.
Agree Realty: The Discount Is Closing, But I See Above $80 In 2026
Envestnet Asset Management Inc. boosted its position in Agree Realty Corporation (NYSE: ADC) by 12.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 319,211 shares of the real estate investment trust's stock after purchasing an additional 36,312
Real estate investment trusts (REITs) tend to shine when there is a lid on interest rates. And that rate top is secure, for reasons we'll review shortly.
Passive income is revenue generated without the earner's continuous active effort, making it a desirable financial strategy for those seeking to diversify their income streams or achieve financial independence.
Agree Realty Corporation (ADC) Q4 2025 Earnings Call Transcript
CEO Abizer Gaslightwala discusses the Company's recent announcement around its ADC pipeline expansion and IP strategy
The headline numbers for Agree Realty (ADC) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Agree Realty (ADC) came out with quarterly funds from operations (FFO) of $1.11 per share, beating the Zacks Consensus Estimate of $1.1 per share. This compares to FFO of $1.04 per share a year ago.